Here, we discover hypoxia-mediated induction of a dominant-negative isoform of eIF2Bε as a secondary method to inhibit translation and increase survival of head and neck cancer cells in periods of acute or prolonged hypoxia. Here, EIF2B5 is linked to head and neck cancer.